Cytomegalovirus chorioretinitis in a patient after allogenic transplantation of hematopoietic stem cells
Cytomegalovirus (CMV) retinitis is a complication of hematopoietic stem cells transplantation (HSCT) and may lead to remarkably decreased vision. The peculiar protocol of diagnostics and treatment of CMV retinitis is developed and implemented in D. Rogachyov’s center. The authors present a clinical case of a 1-year old boy with acute myelogenous leukemia who underwent allogenic HSCT with cTCR αβ/ CD 19 depletion. CMV retinitis manifested on 60th day after HSCT. Due to a series of antiviral drugs intravitreal injections the inflammation gradually regressed.